Pharma Equity Group A/S: Financial statements 2022
CVR: 26791413
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pharma Equity Group A/S (CVR 26791413) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK 3,479,000 compared with DKK 5,391,000 the year before. Equity in the 2022 report amounted to DKK 46,045,000. The solvency ratio was 64.8%.
- Profit/Loss
- DKK 3,479,000
- Equity
- DKK 46,045,000
- Total Assets
- DKK 71,072,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | 3.5 mio. | 46 mio. | - |
| 2021 | - | - | 5.4 mio. | 42.6 mio. | - |
| 2020 | - | - | -32.9 mio. | 34.3 mio. | - |
| 2019 | - | - | -14.4 mio. | 67.2 mio. | - |
| 2018 | - | - | -7.7 mio. | 77.6 mio. | - |
Official annual report
Keep an eye on Pharma Equity Group A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pharma Equity Group A/S has published its interim report for the period January 1, 2022 – June 30, 2022.
Pharma Equity Group A/S has published its annual report for 2021. The net result was DKK 5,391,000.
As of April 27, 2022, Peter Ole Jensen is registered as adm. dir. of Pharma Equity Group A/S.
As of April 27, 2022, Jeanette Gyldstoff Borg has stepped down as adm. dir. of Pharma Equity Group A/S.
As of April 25, 2022, Claus Abildstrøm has joined the board of directors of Pharma Equity Group A/S.
As of April 25, 2022, Peter Mørch Eriksen has joined the board of directors of Pharma Equity Group A/S.
As of April 25, 2022, Peter Ole Jensen has joined the board of directors of Pharma Equity Group A/S.
As of April 25, 2022, Jeanette Gyldstoff Borg has left the board of directors of Pharma Equity Group A/S.
As of April 24, 2022, Claus Abildstrøm has left the board of directors of Pharma Equity Group A/S.
As of April 24, 2022, Peter Ole Jensen has left the board of directors of Pharma Equity Group A/S.
About Pharma Equity Group A/S
Pharma Equity Group A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2002. The company is registered under the industry Investering for egen regning. The company was previously named BLUE VISION A/S and GUDME RAASCHOU VISION A/S. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Charlotte Pahl, Lars Rosenkrantz Gundorph and Omar Siraj M Qandeel. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000.